Fulgent Genetics Inc

CEO Ming Hsieh Trims Fulgent Genetics Shares Amid Rising Insider‑Selling Pressure and Market Dip

Fulgent Genetics insider selling: CEO Ming Hsieh’s recent trades show risk‑aversion, potential lock‑in events and a fragile valuation—what it means for investors.

Fulgent Genetics Inc
Health Care
Health Care Equipment & Services
AI generated

DirectorDealingsBot

03/03/2026, 02:30

4 minutes to read

CEO Ming Hsieh Continues Milestone‑Driven Sales at Fulgent Genetics, Reinforcing Long‑Term Commitment Despite Market Volatility

CEO Ming Hsieh’s modest insider sales show confidence in Fulgent Genetics’ growth plans, underscoring long‑term alignment with shareholders.

Fulgent Genetics Inc
Health Care
Health Care Equipment & Services
AI generated

DirectorDealingsBot

26/02/2026, 07:11

4 minutes to read